会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
    • 包含的组合物,涉及的方法和非天然氨基酸和多肽的使用
    • WO2011028195A3
    • 2011-06-16
    • PCT/US2007088009
    • 2007-12-18
    • AMBRX INCMIAO ZHENWEILIU JUNJIE
    • MIAO ZHENWEILIU JUNJIE
    • C07D209/20A61K38/02C07D209/08C07D209/56C07K1/107C07K2/00G01N33/68
    • C07D209/10C07D209/20C07D209/94
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of functionalities, but typically have at least one indole, carbonyl, and/or hydrazine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one indole, carbonyl, and/or hydrazine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括宽范围的官能团,但通常具有至少一个吲哚,羰基和/或肼基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,经修饰的非天然氨基酸多肽包括至少一个吲哚,羰基和/或肼基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 2. 发明申请
    • COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
    • 包含的组合物,涉及的方法和非天然氨基酸和多肽的使用
    • WO2007079130A2
    • 2007-07-12
    • PCT/US2006/049397
    • 2006-12-27
    • AMBRX, INC.MIAO, ZhenweiLIU, Junjie
    • MIAO, ZhenweiLIU, Junjie
    • A61K38/16
    • C07K1/1072C07D231/12C07K14/61C12N9/93
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括多种可能的功能,但典型的具有至少一个杂环,醛醇基,二羰基和/或二胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个杂环,醛醇基,二羰基和/或二胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 6. 发明申请
    • COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
    • 包含的组合物,涉及的方法和非天然氨基酸和多肽的使用
    • WO2007079130A3
    • 2008-09-25
    • PCT/US2006049397
    • 2006-12-27
    • AMBRX INCMIAO ZHENWEILIU JUNJIE
    • MIAO ZHENWEILIU JUNJIE
    • A01N37/18A61K38/00
    • C07K1/1072C07D231/12C07K14/61C12N9/93
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one heterocycle, aldol-based, dicarbonyl, and/or diamine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括多种可能的功能,但典型的具有至少一个杂环,醛醇基,二羰基和/或二胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个杂环,醛醇基,二羰基和/或二胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 7. 发明申请
    • COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
    • 包含的组合物,涉及的方法和非天然氨基酸和多肽的使用
    • WO2007070659A2
    • 2007-06-21
    • PCT/US2006047822
    • 2006-12-13
    • AMBRX INCMIAO ZHENWEILIU JUNJIENORMAN THEA
    • MIAO ZHENWEILIU JUNJIENORMAN THEA
    • A61K39/395C12P21/06
    • C07K2/00C07C229/42C07K1/006
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one aromatic amine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one alkylated amine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括广泛范围的可能的官能团,但典型地具有至少一个芳族胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个烷基化胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。